News | The Biotech Times

Featured Articles

Pharmaceuticals

Regulatory Science

GH Research publishes Phase 2a PPD data for inhaled GH001

All ten patients in GH Research's open-label trial achieved remission within two hours of a single inhaled dose of mebufotenin, the company reports.

All ten patients in GH Research's open-label trial achieved remission within two hours of a single inhaled dose of mebufotenin, the company reports.

The Biotech Times Editorial Team · 5 June 2026
Regulatory Science

Amplia launches Phase 2b narmafotinib trial in pancreatic cancer

Amplia Therapeutics is initiating a daily-dosing Phase 2b study of its FAK inhibitor narmafotinib in advanced pancreatic cancer, with enrolment due by Q4 2026.

Amplia Therapeutics is initiating a daily-dosing Phase 2b study of its FAK inhibitor narmafotinib in advanced pancreatic cancer, with enrolment due by Q4 2026.

The Biotech Times Editorial Team · 2 June 2026
Diagnostics

Jelly Lean gummy supplement rides viral "Pink Gelatin Trick" wave

A ClickBank-distributed ACV and BHB gummy has surged in searches after a viral pre-meal satiety trend, but counterfeit listings cloud the market.

A ClickBank-distributed ACV and BHB gummy has surged in searches after a viral pre-meal satiety trend, but counterfeit listings cloud the market.

The Biotech Times Editorial Team · 6 May 2026
Digital Health

KFSH Named Saudi Arabia's Most Valuable Healthcare Brand

King Faisal Specialist Hospital and Research Centre (KFSH) has been named Saudi Arabia & the Middle East’s Most Valuable Healthcare Brand for the fourth consecutive year

King Faisal Specialist Hospital and Research Centre (KFSH) has been named Saudi Arabia and the Middle East’s Most Valuable Healthcare Brand for the fourth consecutive year, with its brand value surpassing USD 1.7 billion (SAR 6.3 billion), according to Brand Finance’s 2026 ran

The Biotech Times Editorial Team · 30 April 2026
AgriTech

MW Does a test

Headline subtitle

test schedule

Mark Walker · 27 April 2026

Medical Devices

Dubai SME Partners with Al Tadawi Healthcare to Boost Emirati-Owned SMEs

Dubai SME has signed a strategic cooperation agreement with Al Tadawi Healthcare Group to expand procurement access, commercial visibility, and growth opportunities for Emirati-owned SMEs

The Biotech Times Editorial Team · 8 March 2026

Taranis Capital Launches Exclusive Global Investor Newsletter for Strategic Insights

Taranis Capital has introduced an invitation-only Global Investor Newsletter to provide sophisticated investors with curated updates on fund activations, sector-specific intelligence, and

The Biotech Times Editorial Team · 5 March 2026

Medical Devices

Ant Group Upgrades AI Health Assistant AQ with DeepSearch for Clinicians

Ant Group enhances its AI-native health assistant AQ with DeepSearch, offering clinicians rapid access to evidence-based guidelines, structured research, and clinical decision support.

The Biotech Times Editorial Team · 12 February 2026

AgriTech

Bioprocessing

Pharmaceuticals

Proteomics

Synthetic Biology

Multiply Labs is revolutionizing cell therapy production with ai

Multiply Labs is revolutionizing cell therapy production with robotic systems and AI-driven digital twins.

Multiply Labs is revolutionizing cell therapy production with robotic systems and AI-driven digital twins, cutting costs by up to 70%, increasing throughput, and reducing contamination ri

The Biotech Times Editorial Team · 4 February 2026

Medical Devices

Harley-Davidson Dubai Raises Men’s Health Awareness Across GCC

For Men’s Health Month, Dubai’s Harley-Davidson Chapter goes viral with a humorous, heartfelt campaign promoting early screening for prostate and testicular cancer, engaging men across th

The Biotech Times Editorial Team · 4 February 2026

Medical Devices

NVIDIA and Eli Lilly Launch AI Co-Innovation Lab to Accelerate Drug Discovery

A strategic collaboration worth up to $1 billion unites NVIDIA and Eli Lilly to harness AI for drug development, speeding up discovery and research with advanced biomedical models.

The Biotech Times Editorial Team · 3 February 2026

Pharmaceuticals

NVIDIA Expands BioNeMo Platform to Accelerate AI-Driven Drug Discovery

NVIDIA has expanded its BioNeMo platform with new models, tools, and partnerships, enabling autonomous, AI-driven biology and drug discovery while reducing R&D costs and speeding up s

The Biotech Times Editorial Team · 2 February 2026

Medical Devices

WHX Dubai Launches Dedicated Biotech & Life Sciences Zone to Drive Regional Innovation

World Health Expo Dubai introduces a Biotech & Life Sciences Zone, highlighting AI-driven research, advanced therapeutics, and regional R&D growth, positioning the Middle East as

The Biotech Times Editorial Team · 28 January 2026

UK Tech Funding Hits $15.3B in 2025, Staying Second Globally

UK tech startups raised $15.3B in 2025, ranking second globally despite a funding dip.

The Biotech Times Editorial Team · 27 January 2026

Medical Devices

World Health Expo to Debut in Dubai in February 2026 with Major Government Participation

World Health Expo (WHX), formerly Arab Health, will debut in Dubai in February 2026, bringing together UAE health authorities, global exhibitors, and healthcare leaders to drive policy di

The Biotech Times Editorial Team · 23 January 2026

Medical Devices

Source Partners with ActiveQuote to Streamline Private Medical Insurance

Source Insurance and ActiveQuote partner to enable advisers to offer Private Medical Insurance directly through the Source platform, simplifying holistic protection solutions and helping

The Biotech Times Editorial Team · 21 January 2026

Medical Devices

Dubai to Host Largest Global Healthcare Gathering in 2026

WHX in Dubai and WHX Labs will unite 270,000 professionals and 4,800 exhibitors from 180 countries, showcasing innovations across medical devices, diagnostics, and lab technologies from 9

The Biotech Times Editorial Team · 15 December 2025

Subscribe to

Featured Articles

Dubai SME has signed a strategic cooperation agreement with Al Tadawi Healthcare Group to expand procurement access, commercial visibility, and growth opportunities for Emirati-owned SMEs

Taranis Capital has introduced an invitation-only Global Investor Newsletter to provide sophisticated investors with curated updates on fund activations, sector-specific intelligence, and

Ant Group enhances its AI-native health assistant AQ with DeepSearch, offering clinicians rapid access to evidence-based guidelines, structured research, and clinical decision support.

Multiply Labs is revolutionizing cell therapy production with robotic systems and AI-driven digital twins, cutting costs by up to 70%, increasing throughput, and reducing contamination ri

For Men’s Health Month, Dubai’s Harley-Davidson Chapter goes viral with a humorous, heartfelt campaign promoting early screening for prostate and testicular cancer, engaging men across th

A strategic collaboration worth up to $1 billion unites NVIDIA and Eli Lilly to harness AI for drug development, speeding up discovery and research with advanced biomedical models.

NVIDIA has expanded its BioNeMo platform with new models, tools, and partnerships, enabling autonomous, AI-driven biology and drug discovery while reducing R&D costs and speeding up s

World Health Expo Dubai introduces a Biotech & Life Sciences Zone, highlighting AI-driven research, advanced therapeutics, and regional R&D growth, positioning the Middle East as

UK tech startups raised $15.3B in 2025, ranking second globally despite a funding dip.

World Health Expo (WHX), formerly Arab Health, will debut in Dubai in February 2026, bringing together UAE health authorities, global exhibitors, and healthcare leaders to drive policy di

Source Insurance and ActiveQuote partner to enable advisers to offer Private Medical Insurance directly through the Source platform, simplifying holistic protection solutions and helping

WHX in Dubai and WHX Labs will unite 270,000 professionals and 4,800 exhibitors from 180 countries, showcasing innovations across medical devices, diagnostics, and lab technologies from 9

Subscribe to The Biotech Times